Table 1.
Variable | Color Doppler Ultrasonography | Computed Tomography | Magnetic Resonance Imaging | Nuclear Medicine Imaging | Digital Subtraction Angiography |
Immediate postoperative graft dysfunction/ATN | Preferred test to establish vascular flowa Strengths: Noninvasive; quick; portable; detailed information on arterial and venous anatomy, flow, velocity. Rules out hydronephrosis and detects early large perinephric collections. Weakness: User-dependant; technical limitations may obscure vasculature |
Not used to establish DGF/ATN Strengths: Can detect other intra-abdominal catastrophes Weakness: Risk of contrast nephropathy due to contrast agents in early postoperative period limits vascular evaluation |
Not used to establish flow Strengths: None Weakness: Lack of contrast agent in early postoperative period limits vascular evaluation |
Preferred test to establish flowa Strengths: Uptake establishes flow; may diagnose leaks Weakness: Not easily available, time consuming, expensive |
Not used |
Urinary tract obstruction | Preferred test Strengths: Can be serially followed for resolution, grade severity Weakness: Cannot differentiate functional obstruction from chronic dilatation |
Strengths: Useful to detect nephrolithiasis-related obstruction and extrinsic causes of obstruction | Not used | Second-line test Strengths: Helps differentiate functional obstruction from chronic dilatation |
Not used |
Transplant renal artery stenosis | Preferred test Strengths: Reasonably high sensitivity in highly trained centers; can be serially followed Weakness: Vessel angulation may limit diagnostic accuracy; operator-dependent, limited specificity, lack of intervention option |
CT angiography not studied extensively in transplants Strengths: Theoretically can achieve high sensitivity and specificity in diagnosis Weaknesses: Risk of contrast nephropathy; lack of intervention option |
Strengths: Confirmatory test in cases of equivocal US findings Weakness: Possible high false-positive rates; risk of NSF in GFR <30 ml/min per 1.73 m2 in gadolinium-based studies |
Not used | Preferred confirmatory second-line test in cases with high suspicion Strength: Simultaneous intervention option Weakness: Risk of contrast nephropathy |
Fluid collections– (hematomas, abscess, lymphocele, urinomas) | Preferred Strengths: Follow serially, simultaneous drainage option Weakness: Low specificity |
Preferred second-line test Strengths: High specificity, follow serially for resolution, define surgical intervention |
Preferred third-line line test Strength: Useful for equivocal CT and/or US findings |
Useful only in cases of urine leaks | Not used |
PTLD | Second-line test Weakness: Small lesions cannot be characterized |
Preferred Strengths: High sensitivity, detects extrarenal graft lesions, aids in staging Weakness: Lacks specificity, biopsy required, contrast agent may be needed |
Preferred Strengths: High sensitivity, detects extrarenal graft lesions, aids in staging Weakness: Lacks specificity, biopsy required, contrast agent may be needed |
Not used | Not used |
Nephrolithiasis | Useful for serial imaging for resolution | Preferred first-line test Strengths: High sensitivity and specificity; contrast agent not needed |
Not used | Not used | Not used |
Biopsy/biopsy complications | Preferred modality for biopsy and detecting postbiopsy complications Weakness: Small complications can be missed |
Preferred test to serially follow selected complications | Not used | Not used | Preferred second-line test Strengths: High sensitivity and specificity, intervention options, detects small lesions Weaknesses: Contrast nephropathy, inherent risk of procedure |
ATN, acute tubular necrosis; DGF, delayed graft function; CT, computed tomography; US, ultrasonography; NSF, nephrogenic systemic fibrosis; PTLD, post-transplant lymphoproliferative disorder.
Imaging modality preference based on center expertise, emergent availability, and individual initial surgical/clinical course.